PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34827631-4	2021	Results: A significant difference in medians between baseline, end of RTX therapy, and 6 months after RTX therapy was observed in Dsg-3 titer (p < 0.001), in the CD8 (p = 0.009), and CD20 counts (p < 0.001).	resiniferatoxin	70-73	desmoglein 3	Homo sapiens	130-135	
34827631-4	2021	Results: A significant difference in medians between baseline, end of RTX therapy, and 6 months after RTX therapy was observed in Dsg-3 titer (p < 0.001), in the CD8 (p = 0.009), and CD20 counts (p < 0.001).	resiniferatoxin	102-105	desmoglein 3	Homo sapiens	130-135	
34827631-6	2021	Only the anti-Dsg-3 titer at the end of RTX therapy demonstrated a slight positive correlation with the PDAI score at baseline (p = 0.046, r = 0.652).	resiniferatoxin	40-43	desmoglein 3	Homo sapiens	14-19